The Bioinformatics Market encompasses software, computational tools, databases, platforms, and analytical services used to collect, manage, analyze, and interpret biological information. Bioinformatics has become an essential component of genomics, transcriptomics, proteomics, metabolomics, drug discovery, precision medicine, clinical diagnostics, and biomedical research.
The market is being driven by the rapid growth of genomic data, increasing adoption of multi-omics research, cloud-based computational infrastructure, pharmaceutical R&D outsourcing, and advances in artificial intelligence. According to Market Research Future, the global Bioinformatics Market was valued at USD 19.04 billion in 2025 and is projected to grow from USD 21.37 billion in 2026 to USD 60.20 billion by 2035, registering a CAGR of 12.2% during the forecast period. North America accounted for approximately 42.1% of global revenue in 2025, while Asia-Pacific is expected to be the fastest-growing regional market at a CAGR of 13.9%.
Get Free Sample PDF Brochure:
https://www.marketresearchfuture.com/sample_request/2265
Market Drivers
Expansion of Multi-Omics Research:
The increasing integration of genomic, transcriptomic, proteomic, and epigenomic information is generating demand for sophisticated bioinformatics platforms. Researchers require unified environments capable of handling multiple biological data types, creating opportunities for integrated analysis solutions.
Rapid Growth of Genomic Data:
The continued expansion of DNA and RNA sequencing is generating enormous datasets that require specialized computational tools. As sequencing throughput increases, hospitals, pharmaceutical companies, universities, and research organizations increasingly rely on bioinformatics systems to convert raw biological information into actionable insights.
Growth of Cloud-Native Genomics:
Cloud computing is transforming the way organizations manage large-scale genomic workloads. Cloud-based systems allow users to scale computing resources according to demand, reduce dependence on local infrastructure, and support collaboration between geographically distributed research teams.
Increasing Adoption of Precision Medicine:
Precision medicine depends on genomic and molecular information to characterize diseases and identify appropriate treatment strategies. Bioinformatics platforms support variant interpretation, biomarker discovery, patient stratification, and genomic clinical decision-making.
Rising Pharmaceutical R&D:
Pharmaceutical and biotechnology companies are increasingly using bioinformatics for target identification, molecular modeling, drug discovery, biomarker development, and clinical research. Pharmaceutical and biotechnology companies accounted for approximately 37.4% of end-user demand in 2025.
Growing Outsourcing to CROs:
The shortage of specialized computational biology professionals is encouraging pharmaceutical sponsors and biotechnology companies to outsource analytical workloads. Bioinformatics services are projected to expand at approximately 13.1% CAGR through 2035, making services one of the fastest-growing market categories.
Artificial Intelligence and Machine Learning:
AI and machine learning are increasingly being applied to variant interpretation, protein-structure prediction, drug discovery, biological modeling, and genomic analysis. These technologies can accelerate the processing of complex datasets and identify patterns that may be difficult to detect using traditional approaches.
Market Challenges
Data Complexity:
Biological datasets are becoming increasingly large and complex. Organizations require powerful computational infrastructure, specialized algorithms, and interdisciplinary expertise to process and interpret information effectively.
Shortage of Computational Biology Talent:
Bioinformatics requires professionals who understand biology, statistics, computer science, and data analysis. A shortage of interdisciplinary talent can delay implementation and encourage organizations to rely on external service providers.
Data Privacy and Sovereignty:
Genomic data is highly sensitive, creating significant requirements around privacy, security, consent, and data residency. Cross-border restrictions can force multinational organizations to establish separate compliant computing environments in different jurisdictions.
Interoperability Issues:
Bioinformatics workflows often involve sequencing instruments, laboratory information management systems, databases, analytical pipelines, and cloud platforms from different vendors. Inconsistent standards can make it difficult to move workflows between systems.
Storage and Computing Costs:
Large-scale sequencing and multi-omics projects require substantial storage and computing capacity. Data-egress charges and infrastructure costs can become significant for organizations processing large datasets through cloud platforms.
Reimbursement Uncertainty:
Clinical bioinformatics applications may face uncertainty regarding reimbursement, particularly when computational interpretation forms part of a diagnostic service. This can affect investment decisions for healthcare providers.
Browse In-depth Market Research Report on Bioinformatics Market:
https://www.marketresearchfuture.com/reports/bioinformatics-market-2265
Market Segmentation
By Products and Services:
Bioinformatics Platforms: Bioinformatics platforms represented approximately 44.9% of market revenue in 2025. Enterprise customers are increasingly consolidating analytical workflows into unified platforms that provide governance, visualization, analysis, and audit capabilities.
Bioinformatics Services: Services are among the fastest-growing categories, with a projected CAGR of 13.1% through 2035. Increasing demand for outsourced genomic interpretation and computational expertise is supporting segment expansion.
Knowledge Management Tools: Knowledge management tools generated approximately USD 4.13 billion in 2025. These tools support curated variant databases, pathway information, genomic evidence, and biological knowledge repositories.
By Application:
Genomics and Transcriptomics: Genomics and transcriptomics accounted for approximately 37% of application revenue in 2025. The segment is supported by increasing sequencing volumes, gene-expression studies, and clinical genomic testing.
Proteomics and Metabolomics: Proteomics and metabolomics are projected to grow at approximately 13.4% CAGR through 2035. Advances in mass spectrometry and increasing demand for functional biological information are contributing to growth.
Chemoinformatics and Drug Design: Chemoinformatics and drug design generated approximately USD 3.24 billion in 2025. Computational approaches are increasingly used for virtual screening, molecular optimization, target identification, and lead development.
Translational Bioinformatics: Translational bioinformatics connects research findings with clinical applications, supporting biomarker development, disease characterization, and personalized healthcare.
Other Applications: Other applications include microbiome analysis, agrigenomics, forensic science, infectious-disease surveillance, and environmental research.
By Deployment Type:
On-Premise: On-premise deployment remains relevant for organizations requiring direct control over infrastructure, sensitive datasets, and computational environments.
Cloud-Based: Cloud-based bioinformatics is expanding rapidly because it provides flexible computing capacity and supports large-scale sequencing projects without requiring organizations to build equivalent local infrastructure.
Web-Based: Web-based platforms provide browser-accessible analytical tools and can simplify collaboration and access for researchers without specialized local systems.
By End User:
Pharmaceutical Companies: Pharmaceutical companies use bioinformatics for drug discovery, target validation, biomarker research, clinical trials, and precision medicine.
Biotechnology Companies: Biotechnology firms use computational biology for genomics, molecular research, biological product development, and therapeutic discovery.
Academic and Research Institutes: Academic institutions represented a significant portion of market demand and use bioinformatics for genomics, population studies, disease research, and multi-omics investigations.
Contract Research Organizations: CROs are projected to be among the fastest-growing end-user categories, with approximately 13.0% CAGR through 2035. Increasing pharmaceutical outsourcing is supporting this expansion.
Hospitals and Clinical Laboratories: Hospitals and clinical laboratories increasingly use bioinformatics for genomic diagnostics, variant interpretation, precision oncology, and molecular testing.
Regional Insights
North America:
North America dominated the global Bioinformatics Market with approximately 42.1% share in 2025. Strong pharmaceutical R&D, advanced genomic infrastructure, clinical sequencing, cloud adoption, and precision-medicine programs support regional leadership.
Europe:
Europe generated approximately USD 5.25 billion in 2025 and remains an important bioinformatics market. Cross-border genomic research, health-data governance, population genomics initiatives, and shared research infrastructure are supporting demand.
Asia-Pacific:
Asia-Pacific is projected to be the fastest-growing region, with a CAGR of approximately 13.9% through 2035. China and India are expanding genomic databases, sequencing capacity, research infrastructure, and precision-medicine initiatives.
South America:
South America is gradually expanding bioinformatics capabilities through academic sequencing centers, oncology diagnostics, infectious-disease surveillance, and research collaborations. Brazil remains an important regional market.
Middle East & Africa:
The Middle East and Africa represent emerging opportunities, particularly through national genomics programs. Saudi Arabia and the UAE are investing in genomic infrastructure, while African research networks are expanding population-genomics capabilities.
Key Players
Illumina, Inc.
Thermo Fisher Scientific Inc.
QIAGEN N.V.
Agilent Technologies
Danaher Corporation
Eurofins Scientific
Revvity, Inc.
Bruker Corporation
Dassault Systèmes
DNAnexus, Inc.
Velsera
SOPHiA GENETICS
Future Outlook
The Bioinformatics Market is expected to experience significant expansion as biological research, healthcare, and pharmaceutical development become increasingly data-driven. MRFR projects the market to reach USD 60.20 billion by 2035 from USD 19.04 billion in 2025, representing a CAGR of 12.2%.
Artificial intelligence and biological foundation models are expected to become increasingly important in protein-structure prediction, variant-effect analysis, drug discovery, and target validation. The focus is likely to shift from standalone AI models toward validated and auditable workflows that can be integrated into research and regulated clinical environments.
Cloud-based consumption models are also expected to gain momentum. Rather than purchasing perpetual software licenses, organizations are increasingly moving toward subscription, per-sample, and usage-based models. This approach enables pharmaceutical companies and research organizations to scale computational resources alongside sequencing volumes.
Another major opportunity lies in federated analysis. Instead of transferring sensitive genomic data across borders, institutions can increasingly move algorithms to distributed datasets. Such architectures could help organizations address data-sovereignty requirements while enabling multinational research.
The convergence of genomics, proteomics, metabolomics, and clinical information will further encourage demand for integrated multi-omics platforms. Pharmaceutical companies and CROs are expected to remain major sources of demand as they increasingly outsource computational workloads.
Overall, expanding genomic data, multi-omics research, cloud computing, AI integration, pharmaceutical outsourcing, and precision medicine are expected to support the long-term Growth of the Bioinformatics Market.
Related Report:
Next Generation Sequencing Market Size
Next Generation Sequencing Market Share
Microfluidic Devices Market Trends
Microfluidic Devices Market Growth
Microfluidic Devices Market Demand
About Market Research Future:
Market Research Future (MRFR) is a global market research and consulting company providing comprehensive market research and consulting services across healthcare, life sciences, pharmaceuticals, medical devices, technology, and other industries. Its reports provide insights into market size, segmentation, regional performance, competitive landscapes, emerging technologies, trends, growth opportunities, and future industry prospects.
Follow Us:
LinkedIn | Twitter
Contact:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
